Nonprofit · EIN 75-2329831
DALLAS VA RESEARCH CORPORATION
Tax-exempt · DALLAS, TX 75216
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| September 30, 2025 | 990 | $3,055,887 | $3,037,593 | $18,294 | $2,527,193 | $180,849 | $2,346,344 |
| September 30, 2024 | 990 | $3,622,319 | $3,317,780 | $304,539 | $2,503,110 | $165,612 | $2,337,498 |
| September 30, 2023 | 990 | $3,181,603 | $3,194,247 | -$12,644 | $2,335,077 | $317,553 | $2,017,524 |
Financial details: 990 for the year ended September 30, 2025
Revenue
- Contributions, gifts and grants
- $2,579,511
- of which government grants
- $372,981
- Program service revenue
- $415,548
- Investment income
- $60,828
- Other revenue
- $0
Expenses
- Grants and similar amounts paid
- $0
- Other salaries and wages
- $1,984,148
- Salaries, compensation and benefits (total)
- $2,348,820
- Professional fundraising fees
- $0
- Legal fees
- $5,950
- Accounting fees
- $28,580
- Travel
- $30,568
- Depreciation
- $880
- Program services (functional)
- $2,028,185
- Management and general (functional)
- $1,009,408
Balance sheet and other
- Total assets, start of year
- $2,503,110
- Total assets, end of year
- $2,527,193
- Total liabilities, end of year
- $180,849
- Net assets, end of year
- $2,346,344
- Land, buildings and equipment
- $762
- Net assets without donor restrictions
- $2,346,344
- Gross receipts
- $3,055,887
- Employees
- 0
- Volunteers
- 0
- Year formed
- 1990
- State of legal domicile
- TX
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended September 30, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| JOHN G MODRALL | DIRECTOR Trustee or director | 1 | $0 | $393,159 | $15,482 |
| RICHARD TYLER MILLER | DIRECTOR Trustee or director | 1 | $0 | $336,881 | $18,434 |
| RAUL RIVERA | SECRETARY Trustee or director, Officer | 1 | $0 | $307,772 | $14,854 |
| JASON CAVE | VICE PRESIDENT Trustee or director, Officer | 1 | $0 | $259,467 | $0 |
| SARAH SPAIN | DIRECTOR Trustee or director | 1 | $0 | $233,769 | $16,731 |
| JAMES P LEPAGE | BOARD PRESIDENT Trustee or director, Officer | 1 | $0 | $230,424 | $18,129 |
| JAMYLAH JACKSON | DIRECTOR Trustee or director | 1 | $0 | $219,811 | $16,648 |
| APRIL CRAWFORD | RESEARCH STUDY Highest-paid employee | 40 | $114,174 | $0 | $0 |
| JAYSON D OQUENDO | FIN/ACCT MANAGER Highest-paid employee | 40 | $112,667 | $0 | $0 |
| PAMELA A HOOKER | DIRECTOR OF HR Highest-paid employee | 40 | $106,311 | $0 | $0 |
| DEBORAH LINDQUIST | EXECUTIVE DIRECTOR/CEO Trustee or director, Officer | 40 | $4,753 | $0 | $0 |
| EDDIE M JENKINS | TREASURER Trustee or director, Officer | 1 | $0 | $0 | $0 |
| WILLIAM MORRIS LAMOREAUX | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
990 for the year ended September 30, 2024: 10 people
| Name | Title | Hours / week | Compensation | From related orgs | Other / benefits |
|---|---|---|---|---|---|
| JOHN G MODRALL MD | DIRECTOR Trustee or director | 1 | $0 | $396,605 | $0 |
| JEFFREY L HASTINGS MD | SECRETARY Trustee or director, Officer | 1 | $0 | $359,165 | $0 |
| RICHARD TYLER MILLER MD | DIRECTOR Trustee or director | 1 | $0 | $311,465 | $0 |
| SARAH SPAIN PHD | DIRECTOR Trustee or director | 1 | $0 | $210,394 | $0 |
| JAMES P LEPAGE PHD | BOARD PRESID Trustee or director, Officer | 1 | $0 | $183,157 | $0 |
| JASON CAVE JD SES | VICE PRESIDE Trustee or director, Officer | 1 | $0 | $183,013 | $0 |
| CYNTHIA FOSLIEN-NASH PHARMD | DIRECTOR Trustee or director | 1 | $0 | $182,557 | $0 |
| JAYSON D OQUENDO MBA | FIN/ACCT MAN Officer | 40 | $108,933 | $0 | $11,689 |
| WILLIAM MORRIS LAMOREAUX JD | DIRECTOR Trustee or director | 1 | $0 | $0 | $0 |
| EDDIE M JENKINS US ARMY CAPT RET | TREASURER Trustee or director, Officer | 1 | $0 | $0 | $0 |
990 for the year ended September 30, 2023: 11 people
| Name | Title | Hours / week | Compensation | From related orgs |
|---|---|---|---|---|
| JOHN G MODRALL MD | DIRECTOR Trustee or director | 1 | $0 | $390,551 |
| JEFFERY L HASTINGS MD | SECRETARY Trustee or director, Officer | 1 | $0 | $329,165 |
| RICHARD TYLER MILLER MD | DIRECTOR Trustee or director | 1 | $0 | $306,783 |
| JAMES P LEPAGE PHD | BOARD PRESID Trustee or director, Officer | 1 | $0 | $249,601 |
| CYNTHIA FOSLIEN-NASH PHARMD | DIRECTOR Trustee or director | 1 | $0 | $158,337 |
| SARAH SPAIN PHD | DIRECTOR Trustee or director | 1 | $0 | $154,307 |
| MATTHEW GUSE | CEO Officer | 40 | $64,147 | $0 |
| WILLIAM MORRIS LAMOREAUX JD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| EDDIE M JENKINS US ARMY CAPT RET | TREASURER Trustee or director, Officer | 1 | $0 | $0 |
| JASON CAVE JD SES | VICE PRESIDE Trustee or director, Officer | 1 | $0 | $0 |
| MICHELE PACKARD-MILAM CAE | EXECUTIVE DI Officer | 50 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 4500 S LANCASTER RD BLDG 43 STE 124, DALLAS, TX 75216-7167
- Principal officer (990 for 2024)
- JAMES P LEPAGE PHD, 4500 S LANCASTER ROAD, DALLAS, TX 75216
- Signed the 990
- JAMES P LEPAGE, PRESIDENT
- Phone
- (214) 857-0351
- Website
- WWW.DVARC.ORG
- Return prepared by
- PANDA ACCOUNTING LLC
Mission
THE MISSION OF THE DALLAS VA RESEARCH CORPORATION IS TO SUPPORT SCIENTIFIC RESEARCH, EDUCATION, AND REHABILITATION TO IMPROVE THE LIVES OF VETERANS AND THEIR FAMILIES.
Program accomplishments
- FARUKHI - FUSION: COMPARE THE OVERALL SURVIVAL (OS) IN PARTICIPANTS WITH PROGRESSIVE PSMA-POSITIVE MCRPC WHO RECEIVE FPI-2265 VERSUS PARTICIPANTS TREATED WITH STANDARD OF CARE.Expenses $125,579
- JEON-SLAUGHTER POINT OF CARE TOOLS/DOD: IDENTIFICATION OF SEX-SPECIFIC APPROACHES TO EITHER DEVELOP NOVEL DIAGNOSTICS AND TREATMENTS OR INCREASE THE EFFECTIVENESS OF CURRENT PRACTICE TO IMPROVE CLINICAL CARE OF WOMEN WITH HEART DISEASE.Expenses $120,856
- CHOI APOLLO: CREATING A TISSUE BANK OF NORMAL AND ABNORMAL TISSUE, BLOOD, URINE, SALIVA, BUCCAL SWABS, AND OTHER BODILY FLUIDS OBTAINED DURING SURGERY. BLOOD AND TISSUE SPECIMEN COLLECTION ANALYZING PROTEOMICS/PROTEOGENOMICS FOR PATIENT TREATMENT.Expenses $114,390
- Expenses $1,667,360 · revenue $415,548
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in September, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | September 30, 2026 | February 16, 2027 | Not due yet |
| 2024 | September 30, 2025 | February 17, 2026 | 990 on file |
| 2023 | September 30, 2024 | February 18, 2025 | 990 on file |
IRS record
- EIN
- 75-2329831
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Hospital or medical research organization
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1991
- Accounting year ends
- September
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H054)
- Assets (IRS master file)
- $2,527,193
- Income (IRS master file)
- $3,055,887
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | September 2025 | $3,055,887 | $3,037,593 | $2,527,193 | IRS |
| 990 | September 2024 | $3,622,319 | $3,317,780 | $2,503,110 | IRS |
| 990 | September 2023 | $3,181,603 | $3,194,247 | $2,335,077 | XML |
| 990 | September 2022 | $1,996,257 | $2,759,735 | $2,168,964 | IRS |
| 990 | September 2021 | – | – | – | IRS |
| 990 | September 2020 | – | – | – | IRS |
| 990 | September 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 75-2329831).
Questions about DALLAS VA RESEARCH CORPORATION
- What is the EIN of DALLAS VA RESEARCH CORPORATION?
- The employer identification number (EIN) of DALLAS VA RESEARCH CORPORATION is 75-2329831.
- Is DALLAS VA RESEARCH CORPORATION tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1991.
- Are donations to DALLAS VA RESEARCH CORPORATION tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does DALLAS VA RESEARCH CORPORATION file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of DALLAS VA RESEARCH CORPORATION due?
- The return for tax year 2025 (the year ending September 30, 2026) is due February 16, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did DALLAS VA RESEARCH CORPORATION last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended September 2025.
- Who is the principal officer of DALLAS VA RESEARCH CORPORATION?
- The 990 for the year ended September 30, 2025 names JAMES P LEPAGE PHD.
- Who are the officers and directors of DALLAS VA RESEARCH CORPORATION?
- The 990 for the year ended September 30, 2025 lists 13 people; 4 received compensation from the organization.
- How much revenue does DALLAS VA RESEARCH CORPORATION have?
- On its 990 for the year ended September 30, 2025 it reported revenue of $3,055,887, expenses of $3,037,593 and total assets of $2,527,193 at year end.
Other nonprofits in DALLAS
- BAYLOR RESEARCH INSTITUTE EIN 75-1921898 · last filed 990 for 2025
- RETINA FOUNDATION OF THE SOUTHWEST EIN 51-0151514 · last filed 990 for 2025
- CHILDRENS MEDICAL CENTER RESEARCH INSTITUTE AT THE UNIVERSITY OF TEX EIN 45-3462044 · last filed 990 for 2024
- NATIONAL OVARIAN CANCER COALITION INC EIN 65-0628064 · last filed 990 for 2024
- KIDNEY CANCER ASSOCIATION EIN 36-3719712 · last filed 990 for 2025
- OSTEOSARCOMA INSTITUTE EIN 82-2921815 · last filed 990 for 2024
- PEDIATRIC EPILEPSY RESEARCH FOUNDATION EIN 20-1779737 · last filed 990-PF for 2024
- CHILDRENS CANCER FUND OF DALLAS INC EIN 75-2113401 · last filed 990 for 2025